Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Fiji.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on July 1, 2025
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewswire
·
July 1, 2025
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 annual …
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 1, 2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
July 1, 2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it …
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
GlobeNewswire
·
July 1, 2025
ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC 12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an …
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
GlobeNewswire
·
July 1, 2025
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including …
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of June 26, 2025, the Board of Directors granted Jean- …
Effective Testosterone Booster for Men Over 50: TestoPrime Medically Accredited as the Best Testosterone Supplement for Males In 40's and 50's
GlobeNewswire
·
July 1, 2025
New York City, NY, July 01, 2025 (GLOBE NEWSWIRE) -- For men in their 40s and 50s seeking a proven, safe, and powerful way to restore youthful energy, muscle, and vitality, a breakthrough solution has arrived. TestoPrime, the most effective testosterone …
Fred Meyer and Washington State Collaborate to Provide Free Locking Bags to Prevent Opioid Misuse
GlobeNewswire
·
July 1, 2025
Olympia, Washington, July 01, 2025 (GLOBE NEWSWIRE) -- Customers at Fred Meyer’s 60 pharmacies in Washington now have access to free locking bags to more safely store their opioid prescriptions. The Washington State Health Care Authority (HCA) is …
Carotenoids Market: Rising Demand for Natural Ingredients and Wellness Products Fuels Global Growth
GlobeNewswire
·
July 1, 2025
Boston, July 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Global Market for Carotenoids” is expected to grow from $2.1 billion in 2024 to $2.9 billion by the end of 2029 at a compound annual growth rate (CAGR) of 6.7% …
Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight
GlobeNewswire
·
July 1, 2025
New York, USA, July 01, 2025 (GLOBE NEWSWIRE) -- Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight The paroxysmal nocturnal …
Global Clinical Trial Support Services Market is Predicted to Cross USD 43 Billion by 2032 | DelveInsight
GlobeNewswire
·
July 1, 2025
New York, USA, July 01, 2025 (GLOBE NEWSWIRE) -- Global Clinical Trial Support Services Market is Predicted to Cross USD 43 Billion by 2032 | DelveInsight The clinical trial support services market is experiencing significant growth, driven by the …
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
GlobeNewswire
·
July 1, 2025
WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the …
CMI Media Group kündigt Event „Agility Berlin 2025“ an; Martin Strobel hält Keynote-Rede
GlobeNewswire
·
July 1, 2025
LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Die strategische Medienagentur für das Gesundheitswesen CMI Media Group, ein Unternehmen der WPP (NYSE: WPP), freut sich, den ersten europäischen Event Agility Berlin: Transformative Thinking, Rx Precision in …
CMI Media Group annonce l’événement Agility Berlin 2025 ; Martin Strobel y tiendra le rôle de conférencier principal
GlobeNewswire
·
July 1, 2025
LONDRES, 01 juill. 2025 (GLOBE NEWSWIRE) -- L’agence stratégique spécialisée dans les médias de santé CMI Media Group, une société du groupe WPP (NYSE : WPP), est fière d’annoncer la tenue du premier événement européen « Agility Berlin: Transformative …
Direct Meds Launches Company-Wide AI Program to Scale Patient Care Amid Explosive Growth
GlobeNewswire
·
July 1, 2025
DRAPER, Utah, July 01, 2025 (GLOBE NEWSWIRE) -- Direct Meds LLC, a fast-scaling telemedicine provider serving the U.S. and Canada, today announced a company-wide deployment of artificial intelligence (AI) technologies to ensure scalable, efficient patient …
Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025
GlobeNewswire
·
July 1, 2025
AURORA, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), a Colorado based company focused on operating in the regulated cannabis markets in the United States, today announced its financial results for the first quarter ended …